Herein, we found that both IMPDH1 and IMPDH2 were significantly upregulated in oxaliplatin-resistant CRC cells, whereas the increase in IMPDH2 was twofold greater than that in IMPDH1. This evidence concerns the gene IMPDH1 and colorectal carcinoma.